Egypt strengthens African cooperation to localize vaccine manufacturing at Africa Health ExCon
The fifth edition of the Africa Health ExCon 2026 witnessed wide participation from officials and experts, with discussions focusing on the development of the health sector across the continent. Egypt was represented at the event by Dr. Ali Al-Ghamrawy, Chairman of the Egyptian Drug Authority, who emphasized the importance of African solidarity in addressing shared health challenges.
During the conference, Dr. Al-Ghamrawy participated in the signing ceremonies for a number of important strategic partnerships. These agreements primarily aim to localize the vaccine industry within Egypt and other African nations, in addition to transferring advanced medical technology to ensure the sustainability of local production.
These steps come within the framework of Egypt's efforts to enhance continental health security. Through these partnerships, officials seek to reduce reliance on importing medicines and vaccines from abroad, and to provide for the needs of citizens in Egypt and Africa at affordable prices and high quality.
These initiatives are part of a broader vision aimed at making Egypt a regional hub for medical and vaccine industries. These agreements are expected to contribute to creating new job opportunities and supporting the national economy, while strengthening the ability of health systems to respond to future crises and pandemics.